Lipid‐Lowering Therapy Use When Indicated and Subsequent Ischemic Stroke Severity
LLT is underused in patients who present with atherosclerosis-related AIS. Lack of prestroke LLT use was associated with more severe stroke symptoms upon presentation. These findings emphasize the need to prescribe LLT when indicated, because its use may mitigate poststroke disability.
Authors
- Samantha Salas
- Kamil F. Faridi (ORCID: https://orcid.org/0000-0002-9276-9110)
- Anisha Garg (ORCID: https://orcid.org/0000-0002-9267-4728)
- Rachel Forman
- Anna Baker (ORCID: https://orcid.org/0000-0002-8874-8827)
- Barbara Gordon‐Kundu
- Adam de Havenon (ORCID: https://orcid.org/0000-0001-8178-8597)
- Kevin Navin Sheth (ORCID: https://orcid.org/0000-0003-2003-5473)
- Richa Sharma (ORCID: https://orcid.org/0000-0003-0798-2353)
- Harlan M. Krumholz (ORCID: https://orcid.org/0000-0003-2046-127X)
- Reza Peyravi (ORCID: https://orcid.org/0009-0007-0854-6568)
- Michael Levien
Institutions
- Yale University (US)
- Center for Discovery (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1161/jaha.123.033365
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00